Azole resistance in oropharyngeal Candida albicans strains isolated from patients infected with human immunodeficiency virus
- PMID: 7840596
- PMCID: PMC284772
- DOI: 10.1128/AAC.38.10.2495
Azole resistance in oropharyngeal Candida albicans strains isolated from patients infected with human immunodeficiency virus
Abstract
For 212 oropharyngeal isolates of Candida albicans, the fluconazole MICs for 50 and 90% of strains tested were 0.5 and 16 micrograms/ml, respectively, and those of itraconazole were 0.05 and 0.2 micrograms/ml, respectively. Of 16 isolates for which fluconazole MICs were > 64 micrograms/ml, itraconazole MICs for 14 were < or = 0.8 micrograms/ml and for 2 were > 6.4 micrograms/ml. Most fluconazole-resistant strains remained susceptible to itraconazole; whether itraconazole will prove effective for refractory thrush remains to be shown.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
